This is further supported by the study of Rezaei and colleagues, which demonstrated that minocycline significantly reduced the expression of MMP-2 and MMP-9 as well as the migratory activity of MCF-7 breast cancer cells [12]. The gene discussed is MMP2; the disease is breast carcinoma.